HALOZYME THERAPEUTICS INC (HALO)       38.64  +0.06 (+0.16%)

38.64  +0.06 (+0.16%)

US40637H1095 - Common Stock - After market: 38.64 0 (0%)

News Image
a month ago - Halozyme Therapeutics, Inc.

Halozyme to Participate in the 2022 Wells Fargo Healthcare Conference

/PRNewswire/ -- Halozyme Therapeutics, Inc. (NASDAQ: HALO) ("Halozyme") today announced that Dr. Helen Torley, president and chief executive officer, is...

News Image
a month ago - Market News Video

Halozyme Therapeutics Becomes Oversold (HALO)

News Image
a month ago - Halozyme Therapeutics, Inc.

Halozyme Therapeutics, Inc. Announces Upsize and Pricing of Private Offering of $625 Million of Convertible Senior Notes due 2028

/PRNewswire/ -- Halozyme Therapeutics, Inc. (NASDAQ: HALO) ("Halozyme" or the "Company"), a leader in converting IV biologics to subcutaneous delivery, today...

News Image
a month ago - BusinessInsider

Halozyme Therapeutics, Inc. Announces Proposed Offering of $500 Million of Convertible Senior Notes due 2028

The Company plans to purchase up to $200 million worth of shares concurrently with, or shortly after, the pricing of the offeringSAN DIEGO, Aug. 1...

News Image
a month ago - Halozyme Therapeutics, Inc.

Halozyme Therapeutics, Inc. Announces Proposed Offering of $500 Million of Convertible Senior Notes due 2028

/PRNewswire/ -- Halozyme Therapeutics, Inc. (NASDAQ: HALO) ("Halozyme" or the "Company"), a leader in converting IV biologics to subcutaneous delivery and...

News Image
2 months ago - Halozyme Therapeutics, Inc.

Positive Results Announced from Phase III IMscin001 Study Evaluating Subcutaneous Formulation of Tecentriq® with ENHANZE® in Advanced Non-Small Cell Lung Cancer

/PRNewswire/ -- Halozyme Therapeutics, Inc. (NASDAQ: HALO) ("Halozyme") today announced that Roche's Phase III IMscin001 study evaluating a subcutaneous (SC)...

News Image
2 months ago - Halozyme Therapeutics, Inc.

Halozyme to Report Second Quarter 2022 Financial and Operating Results

/PRNewswire/ -- Halozyme Therapeutics, Inc. (NASDAQ: HALO) ("Halozyme") today announced it will release its second quarter 2022 financial and operating results...

News Image
2 months ago - Market News Video

First Week of HALO March 2023 Options Trading

News Image
3 months ago - InvestorPlace

7 Biotech Stocks With Key Catalysts Coming in July

Biotech stocks have had a rocky few months, but many are on the mend. These picks should provide investors both flexibility and growth.

News Image
4 months ago - Halozyme Therapeutics, Inc.

Halozyme to Participate in the Goldman Sachs 43rd Annual Global Healthcare Conference

/PRNewswire/ -- Halozyme Therapeutics, Inc. (NASDAQ: HALO) ("Halozyme") today announced that Dr. Helen Torley, president and chief executive officer, is...

News Image
5 months ago - Market News Video

HALO Crosses Below Key Moving Average Level

News Image
5 months ago - Halozyme Therapeutics, Inc.

Halozyme To Host First Quarter 2022 Financial Results Webcast and Conference Call

/PRNewswire/ -- Halozyme Therapeutics, Inc. (NASDAQ: HALO) will webcast its Quarterly Update Conference Call for the first quarter 2022 on May 10 at 4:30 p.m....

News Image
6 months ago - Weiss Law

SHAREHOLDER ALERT: Weiss Law Investigates Antares Pharma, Inc.

/PRNewswire/ -- Weiss Law is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Antares Pharma, Inc....

News Image
6 months ago - InvestorPlace

Why Is Sierra Oncology (SRRA) Stock Up Today?

Late-phase cancer treatment company Sierra Oncology is up big today after being acquired by GlaxoSmithKline. SRRA stock is soaring.

News Image
6 months ago - InvestorPlace

Why Is Antares Pharma (ATRS) Stock Up Today?

Antares Pharma (ATRS) stock is rocketing higher on Wednesday after the company reached an acquisition agreement with Halozyme (HALO).

News Image
6 months ago - Investor's Business Daily

Biotech Stock Sierra Soars On GSK Buyout As Halozyme Nabs Antares

GlaxoSmithKline said Wednesday it will buy Sierra Oncology for $1.9 billion, sending the biotech stock flying.